Yi Hu

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

Yan Xu, Zheng Xiang, Mohammed Alnaggar et al. · Cellular and Molecular Immunology · 2020 · 232 citations · Full text

Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway

Nianshuang Li, Yan Feng, Yi Hu et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 142 citations · Full text

Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

Mohammed Alnaggar, Yan Xu, Jingxia Li et al. · Journal for ImmunoTherapy of Cancer · 2019 · 125 citations · Full text

Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to <i>H. pylori</i> infection

Chuan Xie, Nianshuang Li, Huan Wang et al. · Gut Microbes · 2020 · 64 citations · Full text

Optimization of vonoprazan‐amoxicillin dual therapy for eradicating <i>Helicobacter pylori</i>infection in China: A prospective, randomized clinical pilot study

Yi Hu, Xin Xu, Yaobin Ouyang et al. · Helicobacter · 2022 · 55 citations